FDASOL 238616 PRICING SCHEDULE ATTACHMENT 2 FINAL 7 19 2021 1 57 PM.pdf

FDA-SOL-1238616

ATTACHMENT 2

PRICING AND INVOICING SCHEDULE

Ref. Deliverable Name Due Date Price

6.6.1 Project Kickoff Presentation

Brief ing Within 5 business days after award

6.6.1 Kickoff Meeting Summary Within 3 business days after

Project Kickoff Meeting

6.6.3 Draf t Work Plan Within 15 business days after

award

6.6.3 Final Work Plan Within 25 business days after

award

6.1 Animal Subject Health

Notif ications

Within 48 hours of animal disease, injury or death.

6.2 Initial Draf t Proposed Study

Protocols

Within 20 business days after award

6.2 Final Proposed Study Protocols Within 40 business days after award

6.3 IACUC Approval of Research

Protocols

Within 70 business days after award

6.3 DEA License Approvals for

Scheduled Research Drugs

Within 70 business days after award, and biweekly until approvals are obtained

6.4 Drug Discrimination Studies Within 480 business days (24

months) after award

6.5 Draf t Report Within 440 business days (22

months) after award

6.5 Final Report Within 480 business days (24

months) after award

6.6.2 Meeting Agendas At least 2 business days prior to

meetings

6.6.2 Meeting Minutes/Notes Within 3 business days after

meetings

6.6.2 Monthly Status Report

Proposed template due no later than 30 business days after award;

monthly reports due the 10th business day of each month

6.6.2 Draf t Project Management

Closure Report

Within 15 business days of project completion

6.6.2 Final Project Management

Closure Report Last day of period of performance

Total (Firm Fixed Price)